Casma Therapeutics fetches $50m Series B
Cambridge, Massachusetts-based Casma Therapeutics Inc., a biotechnology company, has secured $50 million in Series B financing.
Cambridge, Massachusetts-based Casma Therapeutics Inc., a biotechnology company, has secured $50 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination